Evidence map›Paper›PMID 29763374›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2018

Transgenic overexpression of CTRP3 prevents alcohol-induced hepatic triglyceride accumulation.

Greta Trogen, Joshua Bacon, Ying Li, Gary L Wright, Ashley Degroat, Kendra L Hagood, Zachary Warren, Allan Forsman, Aruna Kilaru, W Andrew Clark and 1 more

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Greta TrogenEast Tennessee State University, Johnson City, Tennessee.
Joshua BaconEast Tennessee State University, Johnson City, Tennessee.
Ying LiQuillen College of Medicine, Department of Biomedical Sciences, East Tennessee State University, Johnson City, Tennessee.
Gary L WrightQuillen College of Medicine, Department of Biomedical Sciences, East Tennessee State University, Johnson City, Tennessee.
Ashley DegroatDepartment of Biomedical Sciences, East Tennessee State University, Johnson City, Tennessee.
Kendra L HagoodDepartment of Biomedical Sciences, East Tennessee State University, Johnson City, Tennessee.
Zachary WarrenEast Tennessee State University, Johnson City, Tennessee.
Allan ForsmanCollege of Public Health, Department of Health Sciences, East Tennessee State University, Johnson City, Tennessee.
Aruna KilaruCollege of Arts and Sciences, Department of Biological Sciences, East Tennessee State University, Johnson City, Tennessee.
W Andrew ClarkAllied Health Sciences, College of Clinical and Rehabilitative Health Sciences, East Tennessee State University, Johnson City, Tennessee.
Jonathan M PetersonQuillen College of Medicine, Department of Biomedical Sciences, East Tennessee State University, Johnson City, Tennessee.ORCID 0000-0002-9873-3880

Funding

The novel adipokine, CTRP3, as an inhibitor of Alcoholic Fatty Liver DiseaseR03AA023612 · NIAAA · EAST TENNESSEE STATE UNIVERSITY · PI PETERSON, JONATHAN M · 2015 to 2016
$146k
NIAAA NIH HHS R03 AA023612
6 · The paper itself

Abstract

This study tested the ability of a novel adipose tissue derived cytokine, C1q TNF-related protein-3 (CTRP3), to prevent alcohol-induced hepatic lipid accumulation, or alcoholic fatty liver disease (ALD). Previous work has demonstrated that CTRP3 is effective at preventing high-fat diet-induced fatty liver; however, the potential of CTRP3 to inhibit ALD has not been explored. To test the potential protective effects of CTRP3, transgenic mice overexpressing CTRP3 (Tg) or wild-type littermates (WT) were subjected to one of two different models of ALD. In the first model, known as the NIAAA model, mice were fed control or alcohol-containing liquid diets (5% vol/vol) for 10 days followed by a single gavage of ethanol (5 g/kg). In the second model, the chronic model, mice were fed control or alcohol-containing diets for 6 wk with no gavage. This study found that CTRP3 reduced triglyceride accumulation in the chronic model of alcohol consumption by ~50%, whereas no reduction was observed in the NIAAA model. Further analysis of isolated primary hepatocytes from WT and Tg mice demonstrated that CTRP3 increased oxygen consumption in the presence of fatty acids, indicating that CTRP3 increases hepatic fatty acid utilization. In conclusion, this study indicates that CTRP3 attenuates hepatic triglyceride accumulation in response to long-term chronic, but not short-term, alcohol consumption.

Indexed as

AdipokinesAnimalsDiet, High-FatEthanolFatty Liver, AlcoholicLipid MetabolismLiverMaleMiceMice, TransgenicTriglyceridesAdipokinesCORS26 protein, mouseEthanolTriglyceridesadipokinesalcoholic steatosis

Identifiers

PMID29763374
PMCPMC6415714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.